Simonetta Geninatti Crich received her Ph.D in Biochemical Sciences in 1997 at the University of Torino under the supervision of prof. S. Aime. She later served as a research technician in the University Chemistry Department, collaborating with different European institutions. Since 2016, she has been associate professor in the Molecular Biotechnology Department, advancing in 2024 to full professor of Inorganic Chemistry. Over the past six years, she has served as the Principal Investigator of one EU project (Attract) and local coordinator for two EU H2020 FET-Open projects.
She is member of ISNCT (International Congress on Neutron Capture Therapy) and the GIDRM (Italian Magnetic Resonance Group) Executive Board. Her research focuses on developing nanosized theranostic agents for selective carborane and MRI delivery in Boron Neutron Capture Therapy for cancer and Alzheimer’s disease. She also explores NMR/MRI applications at low magnetic fields to classify tumor malignancy with and without the use of contrast agents.